Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.

Cells - 30 Apr 2020

Klimczak Aleksandra, Zimna Agnieszka, Malcher Agnieszka, Kozlowska Urszula, Futoma Katarzyna, Czarnota Jaroslaw, Kemnitz Pawel, Bryl Anna, Kurpisz Maciej

Abstract excerpt

Duchenne muscular dystrophy (DMD) is a genetic disorder associated with a progressive deficiency of dystrophin that leads to skeletal muscle degeneration. In this study, we tested the hypothesis that a co-transplantation of two stem/progenitor cell populations, namely bone marrow-derived mesenchymal stem cells (BM-MSCs) and skeletal muscle-derived stem/progenitor cells (SM-SPCs), directly into the dystrophic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Fusion
Share to Dystrophin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electromyography

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Muscle Development

Share to Muscular Dystrophy, Duchenne

Share to Tissue Donors

Source

Open in PubMed Open full text

Identifiers

PMID: 32365922
DOI: 10.3390/cells9051119
PMCID: PMC7290387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.PMID 32365922Read ↗

Systemic cell therapy for muscular dystrophiesSemantic proximity Read ↗

Muscle‐derived stem cells: Potential for muscle regenerationSemantic proximity Read ↗

Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal MuscleSemantic proximity Read ↗

Molecular and cell-based therapies for muscle degenerations: a road under constructionSemantic proximity Read ↗

Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement TherapySemantic proximity Read ↗

Duchenne muscular dystrophy: current cell therapiesSemantic proximity Read ↗

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an <i>in vitro</i> model and for therapy of muscular dystrophiesSemantic proximity Read ↗

Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patientsSemantic proximity Read ↗

Invited review: Stem cells and muscle diseases: advances in cell therapy strategiesSemantic proximity Read ↗

Generation of allogeneic and xenogeneic functional muscle stem cells for intramuscular transplantationSemantic proximity Read ↗

Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy.Semantic proximity Read ↗

Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.